Key player · Company profile
Sanofi S.A
Named as a key player in 165 of our reports, across 33 regions and countries.
Named as a key player in 165 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 5
Brazil 5
Canada 5
China 5
Ecuador 5
Egypt 5
France 5
Germany 5
Hong Kong 5
India 5
Italy 5
Japan 5
Kenya 5
Malaysia 5
Mexico 5
New Zealand 5
Philippines 5
Russia 5
Saudi Arabia 5
Singapore 5
South Africa 5
Spain 5
Thailand 5
UAE 5
UK 5
US 5| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Drugs | OTC & Nutraceuticals | $178 Bn | 4.7% |
| Over The Counter (OTC) Pharmaceuticals | OTC & Nutraceuticals | $178 Bn | 4.7% |
| Over The Counter (OTC) Vitamins and Minerals | OTC & Nutraceuticals | $32 Bn | 5.5% |
| Cardiovascular Health Supplements | OTC & Nutraceuticals | $6.8 Bn | 5.7% |
| Over The Counter (OTC) Sleep Aid Products | OTC & Nutraceuticals | $5.3 Bn | 4% |
Named as key players in the same markets as Sanofi S.A (number of shared markets).
GSK PLC4 shared markets
Johnson & Johnson3 shared markets
Novartis AG3 shared markets
Pfizer Inc.3 shared markets
Abbott Laboratories2 shared markets
AstraZeneca2 shared markets
Merck & Co., Inc.2 shared markets
Reckitt Benckiser Group PLC2 shared markets